| Life Care Center Of Gwinnett | |
| 3850 Safehaven Drive, Lawrenceville, Georgia 30044 | |
| (770) 923-0005 | |
| Name | Life Care Center Of Gwinnett |
|---|---|
| Location | 3850 Safehaven Drive, Lawrenceville, Georgia |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 163 |
| Occupancy Rate | 40.25% |
| Medicare ID (CCN) | 115347 |
| Legal Business Name | Life Care Centers Of America, Inc. |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1295768950 |
| Organization Name | LIFE CARE CENTERS OF AMERICA, INC. |
| Doing Business As | LIFE CARE CENTER OF GWINNETT |
| Address | 3850 Safehaven Dr, Lawrenceville, GA 30044 |
| Phone Number | 770-923-0005 |
News Archive
The head of the U.S. Food and Drug Administration has proposed charging compounding pharmacies fees to pay for the oversight needed to prevent a recurrence of the meningitis outbreak that killed 50 people and sickened hundreds more.
CRISPR-Cas9 is a powerful new tool for editing the genome. For researchers around the world, the CRISPR-Cas9 technique is an exciting innovation because it is faster and cheaper than previous methods. Now, using a molecular trick, Dr. Van Trung Chu and Professor Klaus Rajewsky of the Max Delbrück Center for Molecular Medicine Berlin-Buch and Dr. Ralf Kühn, MDC and Berlin Institute of Health, have found a solution to considerably increase the efficiency of precise genetic modifications by up to eightfold.
PROLOR Biotech, Inc.,, a clinical stage company developing next generation biobetter therapeutic proteins, today announced that the European Commission and the European Medicines Agency (EMA) has granted PROLOR the designation of "Small and Medium Sized Enterprise" (SME).
With growing evidence that a measurement of the buildup of calcium in coronary arteries can predict heart disease risk, Los Angeles Biomedical Research Institute (LA BioMed) researchers found that the process of "calcium scoring" was also accurate in predicting the chances of dying of heart disease among adults with little or no known risk of heart disease.
› Verified 5 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
The head of the U.S. Food and Drug Administration has proposed charging compounding pharmacies fees to pay for the oversight needed to prevent a recurrence of the meningitis outbreak that killed 50 people and sickened hundreds more.
CRISPR-Cas9 is a powerful new tool for editing the genome. For researchers around the world, the CRISPR-Cas9 technique is an exciting innovation because it is faster and cheaper than previous methods. Now, using a molecular trick, Dr. Van Trung Chu and Professor Klaus Rajewsky of the Max Delbrück Center for Molecular Medicine Berlin-Buch and Dr. Ralf Kühn, MDC and Berlin Institute of Health, have found a solution to considerably increase the efficiency of precise genetic modifications by up to eightfold.
PROLOR Biotech, Inc.,, a clinical stage company developing next generation biobetter therapeutic proteins, today announced that the European Commission and the European Medicines Agency (EMA) has granted PROLOR the designation of "Small and Medium Sized Enterprise" (SME).
With growing evidence that a measurement of the buildup of calcium in coronary arteries can predict heart disease risk, Los Angeles Biomedical Research Institute (LA BioMed) researchers found that the process of "calcium scoring" was also accurate in predicting the chances of dying of heart disease among adults with little or no known risk of heart disease.
› Verified 5 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $8175 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 26.09 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 15.14 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 68 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 3 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 2.45 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 1.36 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 90.45 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 12.5 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 91.51 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 4.23 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 59.72 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 22.17 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 16.76 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 87.71 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 56.5 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 88.2 | 82.93 |
News Archive
The head of the U.S. Food and Drug Administration has proposed charging compounding pharmacies fees to pay for the oversight needed to prevent a recurrence of the meningitis outbreak that killed 50 people and sickened hundreds more.
CRISPR-Cas9 is a powerful new tool for editing the genome. For researchers around the world, the CRISPR-Cas9 technique is an exciting innovation because it is faster and cheaper than previous methods. Now, using a molecular trick, Dr. Van Trung Chu and Professor Klaus Rajewsky of the Max Delbrück Center for Molecular Medicine Berlin-Buch and Dr. Ralf Kühn, MDC and Berlin Institute of Health, have found a solution to considerably increase the efficiency of precise genetic modifications by up to eightfold.
PROLOR Biotech, Inc.,, a clinical stage company developing next generation biobetter therapeutic proteins, today announced that the European Commission and the European Medicines Agency (EMA) has granted PROLOR the designation of "Small and Medium Sized Enterprise" (SME).
With growing evidence that a measurement of the buildup of calcium in coronary arteries can predict heart disease risk, Los Angeles Biomedical Research Institute (LA BioMed) researchers found that the process of "calcium scoring" was also accurate in predicting the chances of dying of heart disease among adults with little or no known risk of heart disease.
› Verified 5 days ago
Life Care Center Of Gwinnett Location: 3850 Safehaven Drive, Lawrenceville, Georgia 30044 Phone: (770) 923-0005 | |
Delmar Gardens Of Gwinnett Location: 3100 Club Drive, Lawrenceville, Georgia 30044 Phone: (770) 923-3100 | |
Northside Gwinnett Extended Care Center Location: 650 Professional Drive, Lawrenceville, Georgia 30046 Phone: (678) 312-3000 | |
Life Care Ctr Of Lawrenceville Location: 210 Collins Industrial Way, Lawrenceville, Georgia 30045 Phone: (678) 442-0777 | |
Mesun Health And Rehabilitation Center Location: 88 Johnson Road, Building #2, Lawrenceville, Georgia 30046 Phone: (404) 367-1907 |